Examining efforts to optimize data sharing for brain health: From global data democratization to collaborative analysis environments Har passerat
Torsdag 25 maj 2023 08:30 - 09:45 G4
Föreläsare: Maryan Zirkle, Ardi Kolah, Kimon Kotronis, Lee Lancashire
Spår: MIE: Special Topic: Caring is Sharing - exploiting value in data for health and innovation
Språk
English
Seminarietyp
Enbart på plats
Kunskapsnivå
Avancerad
Konferens
MIE
Författare
Maryan Zirkle, Ardi Kolah, Kimon Kotronis, Lee Lancashire
Föreläsare
Ardi Kolah Föreläsare
Senior Global Privacy Advisor
Selenite Consultants
Ardi Kolah is global privacy, data protection and cybersecurity advisor to Cohen Veterans Bioscience and Dentons Global. He’s worked with some of the world’s NYSE-leading companies including Accenture, Hitachi, Shell, IBM, SolarWinds, Disney and is Founding Editor-in-Chief of the SCOPUS-indexed Journal of Data Protection & Privacy published globally.
Kimon Kotronis Föreläsare
Senior Director Solutions Architecture
Cohen Veterans Bioscience
Kimon Kotronis is a medically trained, Health and Life Sciences digital expert with a long career in designing and developing innovative solutions for Healthcare and Life Sciences organizations ranging from Primary Practice Electronic Health Records, Clinical Decision Support systems and e-Learning resources to Pharmacovigilance, Regulatory, Bioinformatics, Clinical and Competitive Intelligence systems for large, global pharmaceutical organizations.
Kimon holds a Medical Degree, a MSc in Health Informatics and a MBA.
Lee Lancashire Föreläsare
Chief Information Officer
Cohen Veterans Bioscience
Dr. Lee Lancashire is a seasoned expert in machine learning and statistics, with more than two decades of experience. He earned his PhD by specializing in the development of artificial neural network-based methodologies and was involved in many of the first applications of neural nets to high-dimensional bioinformatics datasets.
Before taking on his current position, Dr. Lancashire spent over five years at Thomson Reuters' IP & Science division, where he led the machine learning and statistical data analysis team. In this role, he managed and delivered analytical projects for an international clientele, which included the majority of the top 10 pharmaceutical companies, as well as government, academic, and non-profit organizations. His projects centered on employing cutting-edge machine learning techniques for molecular profiling of diseases, with the aim of discovering biomarkers, stratifying patients, and identifying drug targets.
Following his PhD, Dr. Lancashire completed post-doctoral research in Biostatistics and Bioinformatics at the Paterson Institute for Cancer Research, a core facility of Cancer Research UK. He further honed his skills as a bioinformatics project lead at personalized medicine and diagnostics companies CompanDX and Almac Diagnostics.
Dr. Lancashire has published over 40 articles in prominent industry journals and holds multiple patents related to the use of neural networks in the biomedical sector. Outside of his professional pursuits, he is dedicated to giving back to the community, volunteering as a trustee for the Ichthyosis Support Group, a charity assisting individuals and families affected by a range of rare skin disorders.